Publications

2021

  1. Saito M, Shibata Y, Ueda K, Suzuki H, Komiyama T, Marino K, Aoki S, Maehata Y, Sano N, Onishi H：Quantification of image quality of intra-fractional cone-beam computed tomography for arc irradiation with various imaging condition. Rep Pract Oncol Radiother, 26(3):495-502. 2021.  Click here»
  2. Chen Z, Nonaka H, Onishi H, Nakatani E, Sato Y, Funayama S, Watanabe H, Komiyama T,  Kuriyama K, Marino K, Aoki S, Araya M, Tominaga L, Saito R, Maehata Y, Oguri M, Saito M：Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study, Journal of Radiation Research, 62(3):457-464. 2021.  Click here»
  3. Saito M, Sano N, Kuriyama K, Komiyama T, Marino K, Aoki S, Maehata Y, Suzuki H, Ueda K, Onishi H：New method for measurement of chest surface motion in lung cancer patients: Quantification using a technique of deformable image registration. Med Dosim, 46(2):111-116. 2021.  Click here»

2020

  1. Suzuki T, Saito M, Onishi H, Mochizuki Z, Mochizuki K, Satani K, Sano N, Aoki S, Marino K, Komiyama T, Takahashi H：Effect of a hydrogel spacer on the intrafractional prostate motion during CyberKnife treatment for prostate cancer. J Appl Clin Med Phys, 2020. ［Online ahead of print］  Click here»
  2. Komiyama T, Saito M, Kuriyama K, Marino K, Aoki S, Saito R, Muramatsu J, Maehata Y, Ze C, Akita T, Yamada T, Sano N, Yoshizawa K, Kazunari A, Hidekazu S, Ueda K, Vu N, Onishi H：Dose Prescription Methods in Stereotactic Body Radiotherapy for Small Peripheral Lung Tumors: Approaches Based on the Gross Tumor Volume Are Superior to Prescribing a Dose That Covers 95% of the Planning Target Volume. Technol Cancer Res Treat, 19: 1533033820974030. 2020.　Click here»
  3. Vu N, Onishi H, Saito M, Kuriyama K, Komiyama T, Marino K, Araya M, Aoki S, Saito R, Nonaka H, Funayama S, Watanabe H, Sano N：Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer. J Radiat Res, 61 (5): 740-746. 2020. Click here»
  4. Onishi H, Shioyama Y, Matsumoto Y, Shibamoto Y, Miyakawa A, Suzuki G, Nishimura Y, Sasaki R, Miyawaki D, Kuriyama K, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Nonaka H, Tominaga L, Saito M, Sano N, Yamada S：Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity. J Radiat Res, 61 (3): 426-430. 2020. Click here»
  5. Saito M, Suzuki T, Sugama Y, Marino K, Sano N, Komiyama T, Aoki S, Maehata Y, Yoshizawa K, Ashizawa K, Suzuki H, Ueda K, Miyasaka Y, Araya M, Takahashi H, Onishi H：Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy. Journal of Radiation Research, 61 (3): 487-493. 2020. Click here»
  6. Saito M, Sano N, Kuriyama K, Komiyama T, Marino K, Aoki S, Maehata Y, Saito R, Suzuki H, Shibata Y, Ueda K, Onishi H：Evaluation of the robustness of 3-dimensional conformal technique with MLC position control into the planning target volume in stereotactic body radiotherapy for lung cancer. Med Dosim, 45 (1): e1-e5. 2020.  Click here»
  7. Saito M, Suzuki H, Sano N, Ashizawa K, Yoshizawa K, Shibata Y, Ueda K, Komiyama T, Marino K, Aoki S, Saito R, Maehata Y, Onishi H：Evaluation of the target dose coverage of stereotactic body radiotherapy for lung cancer using helical tomotherapy: A dynamic phantom study. Rep Pract Oncol Radiother, 25(2):200-205. 2020.　Clicke here»
  8. Suzuki T, Saito M, Onishi H, Mochizuki K, Satani K, Yamazaki A, Miura K, Taka S, Sano N, Komiyama T, Takahashi H：Comparison of CT artifacts and image recognition of various fiducial markers including two types of thinner fiducial markers for CyberKnife treatment. Rep Pract Oncol Radiother, 25(1):117-124. 2020.　Click here»
  9. Umezawa R, Kadoya N, Ota H, Nakajima Y, Saito M, Takagi H, Takanami K, Takahashi N, Ishikawa Y, Yamamoto T, Matsushita H, Takeda K, Takase K, Jingu K：Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study. Adv Radiat Oncol, 5 (6): 1170-1178. 2020.  Click here»
  10. Miyasaka Y, Kadoya N, Ito K, Umezawa R, Kubozono M, Yamamoto T, Nakajima Y, Saito M, Takayama Y, Nemoto K, Iwai T, Jingu K：Quantitative analysis of intra-fractional variation in CT-based image guided brachytherapy for cervical cancer patients. Phys Med, 73: 164-172. 2020.  Click here»
  11. Nakajima Y, Kadoya N, Kanai T, Saito M, Kito S, Hashimoto S, Karasawa K, Jingu K：Evaluation of the effect of user-guided deformable image registration of thoracic images on registration accuracy among users. Med Dosim, 45 (3): 206-212. 2020.  Click here»

 

2019

  1. Nonaka H, Onishi H, Watanabe M, Nam VH：Assessment of abdominal organ motion using cine magnetic resonance imaging in different gastric motilities: a comparison between fasting and postprandial states. J Radiat Res, 60 (6): 837-843. 2019. Click here»
  2. Onishi H：Verification of meta-analysis and propensity-matched analysis comparing stereotactic body radiation therapy versus surgery for early stage lung cancer. J Thorac Dis, 11 (6): 2201-2204. 2019. Click here»
  3. Onishi H：Stereotactic body radiotherapy for lung cancer in patients with interstitial lung disease. Therapeutic Radiology and Oncology, 3: 13. 2019.　Click here»　
  4. Wujanto C, Vellayappan B, Siva S, Louie AV, Guckenberger M, Slotman BJ, Onishi H, Nagata Y, Liu M, Lo SS：Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer. Front Oncol, 9: 1219. 2019. Click here»
  5. Kadoya N, Kito S, Kurooka M, Saito M, Takemura A, Tohyama N, Tominaga M, Nakajima Y, Fujita Y, Miyabe Y：Factual survey of the clinical use of deformable image registration software for radiotherapy in Japan. J Radiat Res, 60 (4): 546-553. 2019. Click here»
  6. Chen Z, Araya M, Onishi H：Proton beam therapy for malignant transformation of intracranial epidermoid cyst. BMJ Case Rep, 12 (7): 2019.　Click here»
  7. Funayama S, Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Nonaka H, Tominaga L, Muramatsu J, Nakagomi H, Kamiyama M, Takeda M：Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy. Technol Cancer Res Treat, 18: 1533033818822329. 2019. Click here»

2018

  1. Saito M, Sano N, Ueda K, Shibata Y, Kuriyama K, Komiyama T, Marino K, Aoki S, Onishi H：Technical Note: Evaluation of the latency and the beam characteristics of a respiratory gating system using an Elekta linear accelerator and a respiratory indicator device, Abches. Med Phys, 45 (1): 74-80. 2018.  Click here»
  2. Saito M, Sano N, Shibata Y, Kuriyama K, Komiyama T, Marino K, Aoki S, Ashizawa K, Yoshizawa K, Onishi H：Comparison of MLC error sensitivity of various commercial devices for VMAT pre-treatment quality assurance. J Appl Clin Med Phys, 19 (3): 87-93. 2018. Click here»
  3. Niibe Y, Jingu K, Onishi H：Oligo-recurrence and Sync-oligometastases. J Thorac Oncol, 13 (4): e59-e60. 2018.　Click here»　
  4. Nguyen TK, Senan S, Bradley JD, Franks K, Giuliani M, Guckenberger M, Landis M, Loo BW, Jr., Louie AV, Onishi H, Schmidt H, Timmerman R, Videtic GMM, Palma DA：Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. Pract Radiat Oncol, 8 (2): e71-e78. 2018.　Click here»
  5. Johno H, Saito M, Onishi H：Prediction-based compensation for gate on/off latency during respiratory-gated radiotherapy. Computational and Mathematical Methods in Medicine, 2018 ：5919467. 2018.　Click here»
  6. Saito M, Shibata Y, Sano N, Kuriyama K, Komiyama T, Marino K, Aoki S, Onishi H：Evaluation of Deformable Image Registration and Dose Accumulation Using Histogram Matching Algorithm between kVCT and MVCT with Helical Tomotherapy. Journal of modern physics, 9 (13): 2274-2285. 2018.  Click here»
  7. Sano N, Saito M, Onishi H, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M：Audio-Visual Biofeedback for Respiratory Motion Management: Comparison of the Reproducibility of Breath-Holding between Visual and Audio Guidance. Journal of modern physics, 9 (13): 2286-2294. 2018.　Click here»
  8. Takagi H, Ota H, Umezawa R, Kimura T, Kadoya N, Higuchi S, Sun W, Nakajima Y, Saito M, Komori Y, Jingu K, Takase K：Left Ventricular T1 Mapping during Chemotherapy-Radiation Therapy: Serial Assessment of Participants with Esophageal Cancer. Radiology, 289 (2): 347-354. 2018.　Click here»
  9. Toita T, Ohno T, Ikushima H, Nishimura T, Uno T, Ogawa K, Onishi H, Dokiya T, Itami J：National survey of intracavitary brachytherapy for intact uterine cervical cancer in Japan. J Radiat Res, 59 (4): 469-476. 2018.  Click here» 
  10. Tamaki Y, Itazawa T, Komiyama T, Nishimura Y, Nakayama Y, Ito H, Ohde Y, Kusumoto M, Sakai S, Suzuki K, Watanabe H, Asamura H：Reply to ‘Addressing the challenge of proper delineation of lymph node stations in modern radiotherapy for lung cancer’. J Radiat Res, 59 (4): 524-525. 2018.  Click here»
  11. Shioyama Y, Onishi H, Takayama K, Matsuo Y, Takeda A, Yamashita H, Miyakawa A, Murakami N, Aoki M, Matsushita H, Matsumoto Y, Shibamoto Y：Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database. Technol Cancer Res Treat, 17: 1533033818783904. 2018.  Click here»
  12. Shibamoto Y, Onishi H：Stereotactic Body Radiotherapy as an Alternative to Definitive Surgery in Cancers of Various Organs. Technol Cancer Res Treat, 17: 1533033818800497. 2018.  Click here»
  13. Onishi H, Yamashita H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Takanaka T, Seo Y, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Tominaga L, Kuriyama K：Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study. Cancers (Basel), 10 (8): 2018.  Click here»
  14. Onishi H, Marino K, Yamashita H, Terahara A, Onimaru R, Kokubo M, Shioyama Y, Kozuka T, Matsuo Y, Aruga T, Hiraoka M：Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer. Technol Cancer Res Treat, 17: 1533033818801323. 2018.   Click here»
  15. Onimaru R, Onishi H, Ogawa G, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H：Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702). Jpn J Clin Oncol, 48 (12): 1076-1082. 2018.  Click here»
  16. Inoue T, Katoh N, Ito YM, Kimura T, Nagata Y, Kuriyama K, Onishi H, Yoshitake T, Shioyama Y, Iizuka Y, Inaba K, Konishi K, Kokubo M, Karasawa K, Kozuka T, Tanaka K, Sakakibara-Konishi J, Kinoshita I, Shirato H：Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study. Lung Cancer, 122: 107-112. 2018.  Click here»
  17. Harada K, Igaki H, Abe E, Ariga T, Hayashi N, Kanemoto A, Komiyama T, Matsumoto Y, Nakano T, Onimaru R, Saito H, Sumi M, Tago M, Tanaka K, Maebayashi K, Aoyama H：Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors. Int J Clin Oncol, 23 (6): 1015-1022. 2018.  Click here»
  18. Katoh N, Onishi H, Uchinami Y, Inoue T, Kuriyama K, Nishioka K, Shimizu S, Komiyama T, Miyamoto N, Shirato H：Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis. Technol Cancer Res Treat, 17: 1533033818809983. 2018.  Click here»

2017

  1. Itazawa T, Tamaki Y, Komiyama T, Nishimura Y, Nakayama Y, Ito H, Ohde Y, Kusumoto M, Sakai S, Suzuki K, Watanabe H, Asamura H：The Japan Lung Cancer Society–Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer. Journal of Radiation Research, 58 (1): 86-105. 2017.  Click here »
  2. Saito M, Kadoya N, Sato K, Ito K, Dobashi S, Takeda K, Onishi H, Jingu K：Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction. J Appl Clin Med Phys, 18 (4): 206-214. 2017.  Click here»
  3. Ito K, Kadoya N, Nakajima Y, Saito M, Sato K, Nagasaka T, Yamanaka K, Dobashi S, Takeda K, Matsushita H, Jingu K：Feasibility of a Direct-Conversion Method from Magnetic Susceptibility to Relative Electron Density for Radiation Therapy Treatment Planning. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 6: 252-265.2017.  Click here»
  4. Nonaka H, Onishi H, Ozaki M, Kuriyama K, Komiyama T, Saito R：Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report. J Med Case Rep, 11 (1): 343. 2017.　Click here»
  5. Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H：Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV100cc. Radiother Oncol, 122 (2): 281-285. 2017.   Click here»
  6. Niibe Y, Jingu K, Onishi H：Long-Term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligo-recurrence. J Thorac Oncol, 12 (11): e191. 2017.   Click here» 
  7. Kimura T, Nagata Y, Harada H, Hayashi S, Matsuo Y, Takanaka T, Kokubo M, Takayama K, Onishi H, Hirakawa K, Shioyama Y, Ehara T：Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). Int J Clin Oncol, 22 (5): 849-856. 2017.  Click here»
  8. Jingu K, Matsuo Y, Onishi H, Yamamoto T, Aoki M, Murakami Y, Yamashita H, Kakuhara H, Nemoto K, Sakayauchi T, Okamoto M, Niibe Y, Nagata Y, Ogawa K：Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer. Anticancer Res, 37 (5): 2709-2713. 2017.   Click here»
  9. Chua KLM, Sin I, Fong KW, Chua MLK, Onishi H：Stereotactic body radiotherapy for early stage lung cancer-historical developments and future strategies. Chin Clin Oncol, 6 (Suppl 2): S20. 2017.   Click here»

2016

  1. Satoh Y, Motosugi U, Nambu A, Saito A, Onishi H：Prognostic Value of Semiautomatic CT Volumetry in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. J Comput Assist Tomogr, 40 (3): 343-50. 2016.　Click here »  
  2. Siva S, Ellis RJ, Ponsky L, Teh BS, Mahadevan A, Muacevic A, Staehler M, Onishi H, Wersall P, Nomiya T, Lo SS：Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma. Future Oncol, 12 (5): 637-45. 2016.　Click here »

2015

  1. Tominaga L, Onishi H, Kuriyama K, Araya M, Aoki S, Saito R, Maehata Y, Oguri M, Sato Y, Kato S：Prediction on Recurrence for Stage ⅠNon-Small Cell Lung Carcinoma by T1-SPECT and FDG-PET. Yamanashi Med J, 30 (20): 47-61. 2015.
  2. Maehata Y, Kuriyama K, Aoki S, Araya M, Marino K, Onishi H：Stereotactic Body Radiotherapy for Localized Ureter Transitional Cell Carcinoma: Three Case Reports. Case Rep Urol, 2015: 519897. 2015.　Click here »
  3. Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H：Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702). Radiother Oncol, 116 (2): 276-80. 2015. Click here »
  4. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura S：Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys, 93 (5): 989-96. 2015.　 Click here » 

2014

  1. Satoh Y, Onishi H, Nambu A, Araki T：Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Radiology, 270 (1): 275-81. 2014.　Click here »
  2. Onishi H, Kawasaki T, Zakoji H, Yoshida T, Komiyama T, Kuriyama K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Marino K, Watanabe I, Oguri M, Araki T, Enomoto N, Takeda M, Katoh R：Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report. BMC Res Notes, 7: 270. 2014.　 Click here»

2013

  1. Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D, Kubota S, Ogo E, Nomiya T, Takemoto M, Harada H, Takahashi I, Ohmori Y, Ishibashi N, Tokumaru S, Suzuki K：Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol, 2013. [Epub ahead of print]　Click here »
  2. Yamashita H, Niibe Y, Toita T, Kazumoto T, Nishimura T, Kodaira T, Eto H, Kinoshita R, Tsujino K, Onishi H, Takemoto M, Hayakawa K：High-dose-rate Intra-cavitary Brachytherapy Combined with External Beam Radiation Therapy for Under 40-Year-old Patients with Invasive Uterine Cervical Carcinoma: Clinical Outcomes in 118 Patients in a Japanese Multi-institutional Study, JASTRO. Jpn J Clin Oncol, 43 (5): 547-52. 2013.　Click here »
  3. Watanabe M, Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga R, Oguri J, Sano N, Araki T：Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors. J Radiat Res, 54 (4): 762-8. 2013.　Click here »
  4. Onishi H, Araki T：Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies. Jpn J Clin Oncol, 43 (4): 345-50. 2013.　Click here »
  5. Niibe Y, Chang JY, Onishi H, Salama J, Hiraki T, Yamashita H：Oligometastases/Oligo-recurrence of lung cancer. Pulm Med, 2013: 438236. 2013.　Click here »
  6. Nambu A, Onishi H, Aoki S, Tominaga L, Kuriyama K, Araya M, Saito R, Maehata Y, Komiyama T, Marino K, Koshiishi T, Sawada E, Araki T：Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors. BMC Cancer, 13: 68. 2013.　Click here »
  7. Matsuo Y, Onishi H, Nakagawa K, Nakamura M, Ariji T, Kumazaki Y, Shimbo M, Tohyama N, Nishio T, Okumura M, Shirato H, Hiraoka M：Guidelines for respiratory motion management in radiation therapy. J Radiat Res, 54 (3): 561-8. 2013.　Click here »
  8. Maehata Y, Onishi H, Kuriyama K, Aoki S, Araya M, Saito R, Tominaga L, Oguri M, Araki T：Immune responses following stereotactic body radiotherapy for stage I primary lung cancer. Biomed Res Int, 2013: 731346. 2013.　Click here »
  9. Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y：Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiat Oncol, 8: 76. 2013.　Click here »
  10. Igaki H, Onishi H, Nakagawa K, Dokiya T, Nemoto K, Shigematsu N, Nishimura Y, Hiraoka M：A newly introduced comprehensive consultation fee in the national health insurance system in Japan: a promotive effect of multidisciplinary medical care in the field of radiation oncology–results from a questionnaire survey. Jpn J Clin Oncol, 43 (12): 1233-7. 2013.　Click here »

2012

  1. Onishi H, Ozaki M, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Oguri M, Watanabe I, Onohara K, Watanabe M, Sano N, Araki T：Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature. Pulm Med, 2012: 713073. 2012.　Click here »
  2. Satoh Y, Nambu A, Onishi H, Sawada E, Tominaga L, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M, Saito R, Maehata Y, Oguri M, Araki T：Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Eur J Radiol, 81 (11): 3530-4. 2012.　Click here»
  3. Onishi H, Ozaki M, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tomiaga L, Oguri M, Watanabe I, Onohara K, Sano N, Araki T：Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer. Acta Oncologica, 51 (5): 624-8. 2012.　Click here »
  4. Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Sano N, Oguri M, Onohara K, Watanabe I, Koshiishi T, Ogawa K, Araki T：Large prostate motion produced by anal contraction. Radiother Oncol, 104 (3): 390-4. 2012.　Click here »
  5. Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H, Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y：Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys, 83 (2): 559-65. 2012.　Click here »

2011

  1. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T：Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys, 81 (5): 1352-8. 2011.　Click here »
  2. Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, Mukumoto N, Teshima T, Mitsumori M：Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey. Int J Radiat Oncol Biol Phys, 81 (5): 1310-8. 2011.　Click here »
  3. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y：Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys, 80 (1): 111-8. 2011.　Click here »
  4. Nambu A, Onishi H, Aoki S, Koshiishi T, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Tominaga L, Maehata Y, Sawada E, Araki T：Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients. Radiat Oncol, 6: 137. 2011.　Click here »
  5. Nakazawa T, Kondo T, Yuminomochi T, Nakazawa K, Ishii Y, Mochizuki K, Kawasaki T, Yamane T, Miyata M, Motosugi U, Katoh R：Fine-needle aspiration biopsy of low-grade cribriform cystadenocarcinoma of the salivary gland. Diagn Cytopathol, 39 (3): 218-22. 2011.　Click here »